Breast Cancer News
In this section, access cutting-edge news about newly diagnosed breast cancer including treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Young women may not be receiving radiation therapy after lumpectomy as often as would be optimal.
An analysis of previous clinical trials may help define situations with a higher risk of recurrence for women who have mastectomy without radiation therapy. The findings may help clarify when doctors should recommend radiation.
Qigong may help ease symptoms of depression in women undergoing radiation treatment for breast cancer and also lessen fatigue in those who reported symptoms of depression before beginning treatment, a study shows.
A retrospective analysis of 4,554 women treated with taxane-based chemotherapy found that though neuropathy is a common side effect, its presence does not predict better outcomes such as longer overall survival or lower risk of recurrence. Neuropathy is damage to the nervous system that causes pain, numbness, tingling or swelling of the hands or feet.
A study using the Oncotype DX test showed a relationship between Recurrence Score and chances of breast cancer recurrence and survival in women with estrogen receptor-positive breast cancer that traveled to the lymph nodes in and around the armpit (axillary lymph nodes) who were treated with hormonal therapy and chemotherapy.
Research shows younger women given pre-surgical, or neoadjuvant, chemotherapy are more likely to have a complete response to that treatment than older women.
A follow-up assessment of data from the National Surgical Adjuvant Breast and Bowel Project B-31 (NSABP B-31) clinical trial showed that adding trastuzumab (Herceptin) to combination chemotherapy treatment raises the risk of heart problems, but they are not long-term.
NEW YORK (Reuters Health) - More than one in five women with early-stage breast cancer in a new study said they were given too much responsibility for treatment-related decisions - and those patients were more likely to end up regretting the choices they made.
NEW YORK (Reuters Health) - Women with a new diagnosis of breast cancer who are covered by Medicare are waiting longer and longer to get treatment, according to a new nationwide study.
A re-analysis of data from the NeoALTTO trial found that women whose tumors disappeared after neoadjuvant, or pre-surgery, treatment, were just as likely to have mastectomy as they were to have lumpectomy.